For the two predefined recategorizations of PGIC, greater proportions of pregabalin subjects gave responses of “much or very much improved” and “any improvement” in comparison with placebo subjects, but the differences in responses did not reach statistical significance ( Table 3 ).
← all excerpts
Efficacy and Safety of Pregabalin for Fibromyalgia in a Population of Chinese Subjects.
1
—
—